THE EUROPEAN Bank for Reconstruction and Development is to lend Euro 21.5 million to Balkanpharma, Bulgaria's leading producer of pharmaceuticals, to support the modernisation of three production sites. It is hoped that the reforms will enable the recently privatised company to raise its standards to meet European Union and Bulgarian official good manufacturing practice levels, allowing it to maintain traditional export and domestic markets and increase its access to the EU.

Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.